TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY

被引：0
|
作者：
Bedane, C. [1 ]
Leccia, M. T. [2 ]
Sassolas, B. [3 ]
Mansard, S. [4 ]
Guillot, B. [5 ]
Mortier, L. [6 ]
Robert, C. [7 ]
Saiag, P. [8 ]
Truchetet, F. [9 ]
Oukessou, A. [10 ]
Bregman, B. [10 ]
Lebbe, C. [11 ]
机构：
[1] Hop Dupuytren, Limoges, France
[2] Hop Michallon, La Tronche, France
[3] Hop Morvan, Brest, France
[4] Hop Hotel Dieu, Clermont Ferrand, France
[5] Hop St Eloi, Montpellier, France
[6] Hop Claude Huriez, Lille, France
[7] Inst Gustave Roussy, Villejuif, France
[8] Hop Ambroise Pare, Boulogne, France
[9] Hop Beauregard, Thionville, France
[10] Bristol Myers Squibb Co, Rueil Malmaison, France
[11] Hop St Louis, Paris, France
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72007-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [1] Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: A retrospective, longitudinal survey (MELODY study)
    Lebbe, C.
    Lorigan, P.
    Ascierto, P.
    Testori, A.
    Bedane, C.
    Middleton, M.
    van Baardewijk, M.
    Konto, C.
    Dueymes, A.
    Maio, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3205 - 3214
  • [2] A RETROSPECTIVE LONGITUDINAL STUDY OF TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH UNRESECTABLE STAGE IIIC/IV MELANOMA IN CANADA (MELODY)
    Osenenko, K.
    Szabo, S. M.
    Schultz, M.
    Mihalcioiu, C.
    Lane, S.
    Levy, A. R.
    VALUE IN HEALTH, 2011, 14 (07) : A433 - A433
  • [3] TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA IN MEXICO
    Silva, A.
    Lazaro-Leon, M.
    de la Pena, R.
    Frausto, P.
    Vargas-Valencia, J. J.
    Gomez-Roel, X.
    Juarez-Garcia, A.
    Donato, B. M. K.
    Martinez-Rivera, G.
    Hernandez-Rivera, G.
    VALUE IN HEALTH, 2012, 15 (04) : A234 - A234
  • [4] MelBase, a French national cohort dedicated to melanoma unresectable stage III and IV patients
    Dalle, S.
    Mortier, L.
    Dutriaux, C.
    Dalac, S.
    Leccia, M.
    Saiag, P.
    Dreno, B.
    Kowal, A.
    Allayous, C.
    Lebbe, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S246 - S246
  • [5] Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA
    Tarhini, Ahmad
    Atzinger, Christopher
    Gupte-Singh, Komal
    Johnson, Courtney
    Macahilig, Cynthia
    Rao, Sumati
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 461 - 473
  • [6] Follow-up of a French national cohort of melanoma stage IV and unresectable stage III patients, MelBase.
    Allayous, Clara
    Dalle, Stephane
    Saiag, Philippe
    Dutriaux, Caroline
    Mortier, Laurent
    Dupuy, Alain
    Lesimple, Thierry
    Bahadoran, Philippe
    Dalac, Sophie
    Marie-Beylot-Barry
    Maubec, Eve
    Stoebner, Pierre-Emmanuel
    Aubin, Francois
    Arnault, Jean-Philippe
    Verneuil, Laurence
    Dreno, Brigitte
    Kowal, Anita
    Porcher, Raphael
    Leccia, Marie Therese
    Lebbe, Celeste
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] The cost of unresectable stage III or stage IV melanoma in Italy
    Michele Maio
    Paolo Ascierto
    Alessandro Testori
    Ruggero Ridolfi
    Emilio Bajetta
    Paola Queirolo
    Michele Guida
    Antonella Romanini
    Vanna Chiarion-Sileni
    Jacopo Pigozzo
    Anna Maria Di Giacomo
    Mario Calandriello
    Guido Didoni
    Marck van Baardewijk
    Cyril Konto
    Carlo Lucioni
    Journal of Experimental & Clinical Cancer Research, 31
  • [8] The cost of unresectable stage III or stage IV melanoma in Italy
    Maio, Michele
    Ascierto, Paolo
    Testori, Alessandro
    Ridolfi, Ruggero
    Bajetta, Emilio
    Queirolo, Paola
    Guida, Michele
    Romanini, Antonella
    Chiarion-Sileni, Vanna
    Pigozzo, Jacopo
    Di Giacomo, Anna Maria
    Calandriello, Mario
    Didoni, Guido
    van Baardewijk, Marck
    Konto, Cyril
    Lucioni, Carlo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [9] EPIDEMIOLOGY, TREATMENT PATTERNS AND COSTS IN PATIENTS WITH STAGE III/IV MELANOMA
    Lugowska, I
    Szkutecka-Debek, M.
    Sozanska-Solak, A.
    Ziobro, M.
    Wysocki, P.
    Barszcz, E.
    Jakubczyk, M.
    Niewada, M.
    VALUE IN HEALTH, 2012, 15 (04) : A215 - A215
  • [10] Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment
    Revicki, Dennis A.
    van den Eertwegh, Alfons J. M.
    Lorigan, Paul
    Lebbe, Celeste
    Linette, Gerald
    Ottensmeier, Christian H.
    Safikhani, Shima
    Messina, Marianne
    Hoos, Axel
    Wagner, Samuel
    Kotapati, Srividya
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
12345